10-114044447-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000684.3(ADRB1):c.315G>T(p.Leu105Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00564 in 1,613,128 control chromosomes in the GnomAD database, including 467 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 252 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 215 hom. )
Consequence
ADRB1
NM_000684.3 synonymous
NM_000684.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.45
Publications
4 publications found
Genes affected
ADRB1 (HGNC:285): (adrenoceptor beta 1) The adrenergic receptors (subtypes alpha 1, alpha 2, beta 1, and beta 2) are a prototypic family of guanine nucleotide binding regulatory protein-coupled receptors that mediate the physiological effects of the hormone epinephrine and the neurotransmitter norepinephrine. Beta-1 adrenoceptors are predominately located in the heart. Specific polymorphisms in this gene have been shown to affect the resting heart rate and can be involved in heart failure. [provided by RefSeq, Sep 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 10-114044447-G-T is Benign according to our data. Variant chr10-114044447-G-T is described in ClinVar as Benign. ClinVar VariationId is 776545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.1 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0296 AC: 4505AN: 152168Hom.: 250 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4505
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00733 AC: 1834AN: 250066 AF XY: 0.00527 show subpopulations
GnomAD2 exomes
AF:
AC:
1834
AN:
250066
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00314 AC: 4583AN: 1460842Hom.: 215 Cov.: 32 AF XY: 0.00272 AC XY: 1978AN XY: 726786 show subpopulations
GnomAD4 exome
AF:
AC:
4583
AN:
1460842
Hom.:
Cov.:
32
AF XY:
AC XY:
1978
AN XY:
726786
show subpopulations
African (AFR)
AF:
AC:
3743
AN:
33472
American (AMR)
AF:
AC:
219
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26124
East Asian (EAS)
AF:
AC:
0
AN:
39692
South Asian (SAS)
AF:
AC:
19
AN:
86246
European-Finnish (FIN)
AF:
AC:
0
AN:
52496
Middle Eastern (MID)
AF:
AC:
35
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
168
AN:
1111948
Other (OTH)
AF:
AC:
398
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
288
577
865
1154
1442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0296 AC: 4514AN: 152286Hom.: 252 Cov.: 32 AF XY: 0.0280 AC XY: 2083AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
4514
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
2083
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
4278
AN:
41556
American (AMR)
AF:
AC:
148
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5158
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30
AN:
68016
Other (OTH)
AF:
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
207
413
620
826
1033
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.